In the past, without modern imaging technologies such as computed tomography (CT) or magnetic resonance imaging (MRI), and positron emission tomography/CT, CEA-pre measurement used to have a significant role as a predictive factor suspecting distant metastasis in CRC patients. The gene discussed is CEACAM5; the disease is colorectal carcinoma.